Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics

被引:0
作者
Hong Liu-Seifert
Haya Ascher-Svanum
Olawale Osuntokun
Kai Yu Jen
Juan Carlos Gomez
机构
[1] Lilly Research Laboratories,
来源
BMC Psychiatry | / 11卷
关键词
Schizophrenia; Haloperidol; Risperidone; Olanzapine; Quetiapine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 380 条
[1]  
McGurk SR(2004)Cognitive effects of olanzapine treatment in schizophrenia MedGenMed 6 27-162
[2]  
Lee MA(2008)The burden of schizophrenia on caregivers: a review Pharmacoeconomics 26 149-211
[3]  
Jayathilake K(2003)Maximizing the synergy between pharmacotherapy and psychosocial therapies for schizophrenia Psychiatr Clin North Am 26 191-1507
[4]  
Meltzer HY(2003)Integrated treatment of schizophrenia Psychiatr Serv 54 1499-14
[5]  
Awad AG(2003)The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999 J Occup Environ Med 45 5-7
[6]  
Voruganti LN(2007)The costs of schizophrenia J Clin Psychiatry 68 4-1129
[7]  
Lauriello J(2005)The economic burden of schizophrenia in the United States in 2002 J Clin Psychiatry 66 1122-1128
[8]  
Lenroot R(2003)Preferences for schizophrenia treatment outcomes among public policy makers, consumers, families, and providers Psychiatr Serv 54 1124-536
[9]  
Bustillo JR(2005)Measuring outcome priorities and preferences in people with schizophrenia Br J Psychiatry 187 529-56S
[10]  
Lenroot R(2005)Clinical Practice guidelines: treatment of schizophrenia Can J Psychiatry 50 1S-70